Inscription Capital, LLC Bristol Myers Squibb CO Transaction History

Inscription Capital, LLC

$661 Million
Q3 2024

A detailed history of Inscription Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Inscription Capital, LLC holds 11,791 shares of BMY stock, worth $688,712. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,791

Previous 12,345 4.49%

Holding current value

$688,712

Previous $512,000 19.14%

% of portfolio

0.09%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $21,971 - $28,669	-554 Reduced 4.49%	11,791 $610,000
Q2 2024 Jul 17, 2024	BUY	$40.25 - $52.99 $91,166 - $120,022	2,265 Added 22.47%	12,345 $512,000
Q1 2024 Jul 17, 2024	SELL	$47.98 - $54.4 $9,068 - $10,281	-189 Reduced 1.84%	10,080 $546,000
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $197,149 - $223,529	4,109 Added 66.7%	10,269 $556,000
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $41,692 - $49,751	860 Added 16.23%	6,160 $316,000
Q3 2023 Oct 17, 2023	BUY	$57.89 - $64.73 $4,283 - $4,790	74 Added 1.42%	5,300 $307,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $7,326 - $8,135	-115 Reduced 2.15%	5,226 $334,000
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $35,811 - $40,618	545 Added 11.36%	5,341 $370,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $517 - $306,130	-3,984 Reduced 45.38%	4,796 $341,000
Q2 2022 Sep 20, 2022	BUY	$72.62 - $79.98 $326,790 - $359,910	4,500 Added 105.14%	8,780 $676,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $1,537 - $1,843	-25 Reduced 0.58%	4,280 $315,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $14,480 - $16,880	270 Added 6.69%	4,305 $268,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $707,495 - $828,739	-11,957 Reduced 74.77%	4,035 $241,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $728,494 - $793,331	11,767 Added 278.51%	15,992 $1.07 Million
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $20,769 - $23,359	350 Added 9.03%	4,225 $269,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $2,887 - $3,271	50 Added 1.31%	3,875 $242,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $219,669 - $243,423	3,825 New	3,825 $231,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $15,617 - $17,269	-350 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$45.12 - $53.8 $20,484 - $24,425	-454 Reduced 56.47%	350 $17,000
Q4 2018 May 16, 2019	BUY	$48.76 - $63.23 $39,203 - $50,836	804 New	804 $42,000

Others Institutions Holding BMY

# of Institutions

2,494

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.

Account

Inscription Capital, LLC Bristol Myers Squibb CO Transaction History